Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Neuphoria Therapeutics Inc (NEUP)

Neuphoria Therapeutics Inc (NEUP)
4.92 x 1 6.44 x 1
Post-market by (Cboe BZX)
5.11 -0.09 (-1.73%) 04/16/25 [NASDAQ]
4.92 x 1 6.44 x 1
Post-market 5.11 unch (unch) 15:56 ET
Quote Overview for Wed, Apr 16th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.97
Day High
5.25
Open 5.25
Previous Close 5.20 5.20
Volume 7,600 7,600
Avg Vol 37,390 37,390
Stochastic %K 40.75% 40.75%
Weighted Alpha -54.35 -54.35
5-Day Change +0.33 (+6.90%) +0.33 (+6.90%)
52-Week Range 2.12 - 15.24 2.12 - 15.24
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,136
  • Shares Outstanding, K 1,757
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,490 K
  • EBIT $ -13 M
  • EBITDA $ -12 M
  • 60-Month Beta 0.25
  • Price/Sales 1,157.63
  • Price/Cash Flow N/A
  • Price/Book 0.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.47
  • Number of Estimates 1
  • High Estimate -0.47
  • Low Estimate -0.47
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.51 +13.30%
on 04/07/25
Period Open: 4.72
6.12 -16.55%
on 03/27/25
+0.39 (+8.26%)
since 03/14/25
3-Month
3.09 +65.37%
on 01/21/25
Period Open: 3.01
12.55 -59.28%
on 01/24/25
+2.10 (+69.77%)
since 01/16/25
52-Week
2.12 +140.58%
on 10/28/24
Period Open: 11.55
15.24 -66.47%
on 05/22/24
-6.44 (-55.76%)
since 04/16/24

Most Recent Stories

More News
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

NEUP : 5.11 (-1.73%)
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

NEUP : 5.11 (-1.73%)
Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes

This payment represents the second milestone in the collaboration between Neuphoria and Merck, with Neuphoria potentially eligible for up to $450 million in additional milestone payments.

NEUP : 5.11 (-1.73%)
MRK : 76.46 (-2.46%)
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

NEUP : 5.11 (-1.73%)
Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

NEUP : 5.11 (-1.73%)

Business Summary

Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.

See More

Key Turning Points

3rd Resistance Point 5.52
2nd Resistance Point 5.39
1st Resistance Point 5.25
Last Price 5.11
1st Support Level 4.97
2nd Support Level 4.84
3rd Support Level 4.70

See More

52-Week High 15.24
Fibonacci 61.8% 10.23
Fibonacci 50% 8.68
Fibonacci 38.2% 7.13
Last Price 5.11
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro